# 510(k) SUMMARY

This summary of ${ \mathfrak { s } } 1 0 \{ { \mathfrak { k } } \}$ safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

# 510(k) Number:

K131128

Date of Summary: Applicant:

Nov. 8, 2013

William R. Corl Chief Executive Officer

Omega Laboratories, Inc. 400 North Cleveland Mogadore, OH 44260 Tel: 330-628-5748 Fax: 330-628-5803

NOV 1 3 2013

# Correspondent: Name:

ROBERT J BARD, JD, CQE, RAC

Address:

Omega Laboratories   
400 North Cleveland, Mogadore, OH 44260   
248-573-5040

Phone Number: E-mail

rbard@reglaw.net

Product Name: Trade Name:

Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites

Common Name: Regulation Number:

Hair Drug Screening Assay Cocaine and Cocaine Metabolites

CFR 862.3250 (ProCode DIO)

Classification Name:

Cocaine and cocaine metabolite test system

Classification Panel: Predicate Device:

91 (Toxicology)

Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites (k112808):

Indication for Use:

The Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites (Cocaine) is an in vitro diagnostic test that is intended for the qualitative detection of Cocaine at or above $5 0 0 \ p g / m g$ in human head and body hair. To confirm a screen positive result, a more specific alternate chemical method, such as Gas Chromatography/Mass Spectrometry (GC/MS) operating in the selected ion monitoring (SiM) mode is the preferred method with deuterated internal standards. Professional judgment should be applied to any drug of abuse test result, particularly when presumptive positive results are obtained.

This test is intended exclusively for single laboratory use only and is not intended for sale to anyone.

# Comparison Performance Data:

When used to qualitatively detect Cocaine and Cocaine Metabolites in head hair specimens collected with the Omega Specimen Collection Device, the Omega assays yield results in substantial agreement with the predicate device (see Table 1 below).   
All performance studies demonstrated that the Omega assay is in substantial agreement with the predicate products.   
Results obtained from donor specimens showed that the qualitative results from the new assays are substantially equivalent to those obtained from the predicate devices.

Table Comparison of Omega Laboratories Cocaine Assay vs Omega Laboratories Cocaine Assay   

<table><tr><td rowspan=1 colspan=1>ComparisonElement-Similarities</td><td rowspan=1 colspan=1>Hair Drug Screening Assay for Cocaine.(Subject devices)</td><td rowspan=1 colspan=1>Hair Drug Screening Assay (Cocaine).(Predicate device)</td></tr><tr><td rowspan=1 colspan=1>Laboratory</td><td rowspan=1 colspan=1>Omega Laboratories, Inc.</td><td rowspan=1 colspan=1>Same.</td></tr><tr><td rowspan=1 colspan=1>Indication for/Intended Use</td><td rowspan=1 colspan=1>The Omega Laboratories Hair DrugScreening Assay for Cocaine and CocaineMetabolites (Cocaine) is an in vitrodiagnostic test that is intended for thequalitative detection of Cocaine at orabove 500 pg/mg in human head and bodyhair. To confirm a screen positive result, amore specific alternate chemical method,such as Gas Chromatography/MassSpectrometry (GC/MS) operating in theselected ion monitoring (SIM) mode is thepreferred method with deuterated internalstandards. Professional judgment shouldbe applied to any drug of abuse test result,particularly when presumptive positiveresults are obtained.This test is intended exclusively for singlelaboratory use only and is not intended forsale to anyone.</td><td rowspan=1 colspan=1>Same.</td></tr><tr><td rowspan=1 colspan=1>Method ofMeasurement</td><td rowspan=1 colspan=1>Microplate reader. Read at 450 nm</td><td rowspan=1 colspan=1>Same.</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Head and body hair</td><td rowspan=1 colspan=1>Head hair</td></tr><tr><td rowspan=1 colspan=1>Cutoffconcentration</td><td rowspan=1 colspan=1>500 pg Cocaine /mg hair</td><td rowspan=1 colspan=1>Same.</td></tr><tr><td rowspan=1 colspan=1>Assay Principal</td><td rowspan=1 colspan=1>ELISA</td><td rowspan=1 colspan=1>Same.</td></tr></table>

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 3 of 22

Table 1: Comparison of Omega Laboratories Cocaine Assay vs Omega Laboratories Cocaine Assay   

<table><tr><td rowspan=1 colspan=1>ComparisonElementSimilaritles</td><td rowspan=1 colspan=1>Hair Drug Screening Assay for Cocaine.(Subject devices)</td><td rowspan=1 colspan=1>Halr Drug Screening Assay (Cocaine).(Predicate device)</td></tr><tr><td rowspan=1 colspan=1>ExtractionMethod</td><td rowspan=1 colspan=1>Utilized acid-methanol vs methanol aloneto facilitate extraction of Cocaine from hair.Proprietary and patent pending method ofpulverizing hair vs cutting the hair intosmall segments prior to acid-methanolextraction. This improved extraction timeswithout loss of efficiency</td><td rowspan=1 colspan=1>Same.</td></tr></table>

# Performance Studies

PRECisioN : Intra-assay precision studies were performed using 11 replicates of negative head hair samples spiked to the following concentrations of cocaine: zero drug. $- 7 5 \%$ . $- 5 0 \%$ . $25 \%$ below the cutoff, and $+2 5 \%$ $+50 \%$ $+ 7 5 \%$ and $+ 1 0 0 \%$ above the cutoff. All samples were treated and analyzed in he same manner as donor hair samples and measured in one run. Head hair was used in this study.

Table 2: Intra-Assay Cocaine Precision Studies (11 replicates/8 concentrations $n = 8 8 )$   

<table><tr><td rowspan=1 colspan=1>Drug</td><td rowspan=1 colspan=1>Concentrationof Sample(pg/mg)</td><td rowspan=1 colspan=1>Number ofRepilcates</td><td rowspan=1 colspan=1>Results #Negative</td><td rowspan=1 colspan=1>Results#Positive</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>0 (Negative)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>125 (-75%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>250 (-50%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>375 (-25%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>625 (+25%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>750 (+50%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>875 (+75%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>1000 (+100%)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>11</td></tr></table>

In   avep i concentrations of cocaine: zero drug. $- 7 5 \%$ . $- 50 \%$ $- 2 5 \%$ below the cutoff, and $+2 5 \%$ $\div 5 0 \%$ $47 5 \%$ and $+ 1 0 0 \%$ above the cutoff. All samples were treated and analyzed in the same manner as donor hair samples. Eleven replicates of these were prepared and analyzed over 20 non-consecutive. The precision of the assay was deemed to be acceptable if the $\% c v$ was less than $15 \%$ .

Table 3: Inter-Assay Cocaine Precision Studies $( \mathsf { C O } { = } 5 0 0 ~ \mathsf { p g / m g } )$ (11 replicates/8 concentrations over 20 n= 1760)   

<table><tr><td rowspan=1 colspan=1>Drug</td><td rowspan=1 colspan=1>Concentration ofSample (pg/mg)</td><td rowspan=1 colspan=1>Number ofReplicates</td><td rowspan=1 colspan=1>Results #Negative</td><td rowspan=1 colspan=1>Results #Positive</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>0 (Negative)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>125 (-75%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>250 (-50%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>375 (-25%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>625 (+25%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>220</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>750 (+50%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>220</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>875 (+75%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>220</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>1000 (+100%)</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>220</td></tr></table>

AGREEMENT: The method comparison was performed by testing 424 hair samples in three studies with the candidate assay and comparing to the reference method, GC/Ms. Each specimen was divided into two aliquots and one was used for screening and the other for GC/Ms confirmation. Testing was performed on body and head hair samples from different ages, gender, ethnicities and hair color. The results were:

Table 4a: Cocaine Agreement Studies (n=424)   

<table><tr><td rowspan=1 colspan=1>ELISA TestResult</td><td rowspan=1 colspan=1>GC/MS Negative(&lt;50 pg/mg)</td><td rowspan=1 colspan=1>GC/MSNegative&lt;250 pg/mg)</td><td rowspan=1 colspan=1>GC/MSNegative (250-499 pg/mg)</td><td rowspan=1 colspan=1>GC/MSPosltive (500-750 pg/mg)</td><td rowspan=1 colspan=1>GC/MS PositIve(&gt;750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>31</td><td rowspan=1 colspan=1>24â€¢</td><td rowspan=1 colspan=1>210</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>122</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Table 4b: GC/MS Summary of Discordant Results   

<table><tr><td rowspan=2 colspan=1>ScreeningCutoff(pg/mg)</td><td rowspan=2 colspan=1>ELISA Test Result(POS/NEG)</td><td rowspan=1 colspan=3>Drug</td><td rowspan=2 colspan=1>GCIMS Drug Result(pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Cocalne</td><td rowspan=1 colspan=1>Benzoylecogonine</td><td rowspan=1 colspan=1>Cocaethylene</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>189</td><td rowspan=1 colspan=1>83</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>272</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>271</td></tr></table>

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites - Page 5 of 22

Table 4b: GC/MS Summary of Discordant Results   

<table><tr><td rowspan=2 colspan=1>ScreeningCutoff(pg/mg)</td><td rowspan=2 colspan=1>ELISA Test Result(POS/NEG)</td><td rowspan=1 colspan=3>Drug.</td><td rowspan=2 colspan=1>GC/MS Drug Result(pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>Benzoylecogonine</td><td rowspan=1 colspan=1>Cocaethyene</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>273</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>273</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>219</td><td rowspan=1 colspan=1>87</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>306</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>251</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>301</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>260</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>310</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>230</td><td rowspan=1 colspan=1>87</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>317</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>278</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>326</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>272</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>337</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>334</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>334</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>238</td><td rowspan=1 colspan=1>116</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>354</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>342</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>342</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>313</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>356</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>335</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>363</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>106</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>390</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>294</td><td rowspan=1 colspan=1>103</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>397</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>354</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>401</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>333</td><td rowspan=1 colspan=1>79</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>412</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>364</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>418</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>328</td><td rowspan=1 colspan=1>98</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>426</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>265</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>448</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>424</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>461</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>393</td><td rowspan=1 colspan=1>77</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>470</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>390</td><td rowspan=1 colspan=1>85</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>475</td></tr></table>

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 6 of 22

Table 4b: GC/MS Summary of Discordant Results   

<table><tr><td rowspan=2 colspan=1>ScreeningCutoff(pg/mg)</td><td rowspan=2 colspan=1>ELISA Test Result(POS/NEG)</td><td rowspan=1 colspan=3>Drug</td><td rowspan=2 colspan=1>GC/MS Drug Result(pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>Benzoylecogonine</td><td rowspan=1 colspan=1>Cocaethylene</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>433</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>475</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>469</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>469</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>444</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>476</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>336</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>462</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>.491</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>491</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>453</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>499</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>497</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>497</td></tr></table>

CROSSREACTIVITY: The Crossreactivity Study demonstrated that the presence of the structurally similar compounds Anhydroecgonine methyl ester, Benzoylecgonine, Benzoylecgonine isopropyl ester, Meta-Hydroxybenzoylecgonine. Cocaine, Cocaethylene, Ecgonine, Ecgonine methyl ester, Norbenzoylecgonine, Norcocaine, and Norcocaethylene may contribute to a Cocaine positive ELISA result when utilizing this protocol. Since a GC/MS confirmation is performed on ll presumptive positive screening results, these compounds will not confirm as a positive result report. None of the other compounds studied demonstrated any interference with the protocol. Head hair was used in this study.

arosactviy ma boaies, ICocai wi Struura mla   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Approximate Concentrationof Compound (pg/mg)Equivalent to 500pg/mgCocalne Cutoff Control(n=3)</td><td rowspan=1 colspan=1>Percent Crossreactivity (%)</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine isopropylester</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>166.7</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>133.3</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>83.3</td></tr><tr><td rowspan=1 colspan=1>Meta-Hydroxybenzoylecgonine</td><td rowspan=1 colspan=1>700</td><td rowspan=1 colspan=1>71.4</td></tr><tr><td rowspan=1 colspan=1>Ecgonine</td><td rowspan=1 colspan=1>80000</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=1 colspan=1>Norbenzoylecgonine</td><td rowspan=1 colspan=1>150000</td><td rowspan=1 colspan=1>0.3</td></tr></table>

Table a: Cross reactivity of Omega Laboratories, Inc.Cocaine LISA with Structurally Similar Compounds   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Approximate Concentrationof Compound (pg/mg)Equivalent to 500pg/mgCocaine Cutoff Control(n=3)</td><td rowspan=1 colspan=1>Percent Crossreactivity (%)</td></tr><tr><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>250000</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>Norcocaethylene</td><td rowspan=1 colspan=1>250000</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>Ecgonine methyl ester</td><td rowspan=1 colspan=1>105000</td><td rowspan=1 colspan=1>0.48</td></tr><tr><td rowspan=1 colspan=1>Anhydroecgonine methyi ester</td><td rowspan=1 colspan=1>250000</td><td rowspan=1 colspan=1>0.2</td></tr><tr><td rowspan=1 colspan=1>Anhydroecgonine</td><td rowspan=1 colspan=2>Not achieved at highest spike concentration.4000000 pg/mg</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=2>Not achieved at highest spike concentration.4000000 pg/mg</td></tr></table>

Although the percent cross-reactivity for Ecognine, Norbenzoylecgonine, Norcocaine, Norcocaethylene, Ecgonine methyl ester and Anhydroecgonine methyl ester could be considered "low", they have been validated and are sufficiently high enough to produce a positive result at these testng concentrations. With the levels f cross-reactivity presented in the table above, these compounds demonstrate positive interference at $-50 \%$ $+ 1 2 5 \%$ and $+ 1 5 0 \%$ of the cut-off. To demonstrate that these drugs are sufficiently cross-reactive, the table below mathematically re-expresses the percent cross-reactivities as cocaine equivalent concentrations at $50 \%$ of the cut-off $( 2 5 0 , 0 9 / \mathrm { m g } )$ , using Anhydroecgonine methyl ester as an example. This was accomplished by multiplying the (Observed Cross-reactivity) by the (Tested Concentration pg/mg) and adding the 250 pg/mg cocaine present in the sample at $- 5 0 \%$ of the cut-off.

Example: Anhydroecgonine methyl ester spiked at 400,000 pg/mg into $-50 \%$ of the cut-off cocaine control sample.

For this calculation we used $0 . 2 \%$ for the Anhydroecgonine methyl ester percent cross-reactivity.

(0.2/100) X (400,000 pg/mg tested concentration) $\yen 800$ pg/mg cocaine equivalents.

800 pg/mg cocaine equivalents $\pm 2 5 0 \ p g / m g$ Cocaine present at $-50 \%$ of the cutoff $=$ 1050 pg/mg combined equivalent cocaine concentration.

This observed concentration is greater than the $5 0 0 p g / m g$ cocaine cutoff control.   
Similar calculations can be made for $+ 1 2 5 \%$ and $150 \%$ of the cut-off.

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 8 of 22

Effect of Interfering Compounds: A variety of structurally related and unrelated compounds were tested for interference'at 10000ng/ml (400000pg/mg) in the Omega Laboratories, Inc. ELISA Cocaine Screening Protocol. Negative hair extracts were spiked with Cocaine at $- 5 0 \%$ (250pg/mg), $+ 1 2 5 \%$ (625pg/mg) and $+ 1 5 0 \%$ (750pg/mg) of the Cocaine Cutoff Concentration (500pg/mg). These were then additionally spiked with 10000ng/ml (400000pg/mg) of the structurally related and unrelated compounds unless otherwise noted. The absorbances were compared to the 500 pg/mg Cocaine cutoff control (C0). Only those compounds that were structurally cross reactive interfered in the assay. These structurally related compounds produced a positive response due to significant cross-reactivity. Compounds tested that were not structurally cross-reactive did not interfere with the assay at any of the tested concentrations. No tested samples produced a negative result when expected to be positive. The analysis was performed in triplicate. Head hair was used for this study.

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>.50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>(-)11-nor-9-carboxy-delta8-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) 11-nor-9-carboxy-deltag-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>R (-) Amphetamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) Cotinine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) Cotinine -N-oxide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) Isoproterenol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) Methamphetamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) Nicotine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-) Phenylephrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(-)-Alpha-methadol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+) Amphetamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+) Isoproterenol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+) Methamphetamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+) Pseudoephedrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) 11-nor-9-carboxy-delta9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) 2,5-Dimethoxy- 4-</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>bromoamphetamine</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>(+/-) Alphaprodine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) Ketamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) MBDB</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) MDA</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) MDEA</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) MDMA</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) Metanephrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) Metoprolol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) Norcotinine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>. (+/-) Propanolol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) Trans-3&#x27;-Hydroxycotinine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>11-Hydroxy-delta9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>19-Nortestosterone(Nandrolone)</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>1R,2S (-) Ephedrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>1S,2R (+) Ephedrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>2-Oxo-3-hydroxy-LSD</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>3-methoxynaltrexone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>3-Trans-Hydrxy-norcotinine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>4-Acetoamidophenol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>4-Hydroxy-Phencyclidine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>5,5-DiphenyIhydantoin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>6-Acetyl-codeine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>6-Monoacetylmorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>7-Aminoclonazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>7-Aminonitrazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Acebutolol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Acetophenetidin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Acetopromazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicyclic acid</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Alfentanil</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Alpha-Ergocryptine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Alprazolam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>7-Aminoflunitrazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Aminorex</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Amitriptyline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Amoxicillin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Anhydroecgonine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Anhydroecgonine methyl ester</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Anileridine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Apomorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Atenolol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Azaperone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine isopropylester</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Betamethasone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Boldenone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Bumetanide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Bupivicaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Buspirone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Butabarbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cannabidiol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Carbamazepine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Carisoprodol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Chlordiazepoxide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cimeterol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Clenbuterol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Clomipramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Clonazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Clonidine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>. +125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Clozapine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Corticosterone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cotinine-N-beta-D-Glucuronide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Cyclobenzaprine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>d,I-N-Desmethylvenlafaxine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Delta8-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Delta9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Deoxycorticosterone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Desalkyiflurazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Desmethyldoxepin (cis/trans)</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Despropionyl-fentanyl</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Dexamethasone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Dextromethorphan</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Diazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Dibucaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Dihydrocodeine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Dihydroergotamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Dihydromorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Diphenhydramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Diphenoxylate</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Diprenorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Dothiepin (cis/trans)</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Doxepin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Droperidol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ecgonlne</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ecgonine methyl ester</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Effexor (Venlafaxine)</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>EMDP</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ergonovine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Estazolam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ethacrynic acid</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ethopropazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Fenfluramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Fentanyl</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Flumethasone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Flunitrazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Fluphenazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Flurazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Furosemide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Gentamicin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Gluthimide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Haloperidol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Heroin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hexobarbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>HMMA</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hydrochlorothiazide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hydrocortisone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>(+/-) 4-Hydroxyephedrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Hydroxymethamphetamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ibogaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Imipramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Ketoprofen</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>LAAM</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Labetalol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>LAMPA (1000ng/ml)</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 15 of 22

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>L-Hyoscyamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Lidocaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Lorazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>LSD</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Lysergic acid</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Lysergol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Maprotiline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Meperidine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Mephentermine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Mepivacaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Metaphit</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Metaproterenol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Metaraminol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Methohexital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Methoxyphenamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Methyiergonovine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Methylphenidate</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>m-Hydroxybenzoylecgonine</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Mianserin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Midazolam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Monensin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Morphine-3-betaglucuronide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Morphine-6-betaglucuronide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nadolol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nalmefene</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nalorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Naloxone-3-beta-D-glucuronide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Naitrexone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Naltriben</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Naproxen</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>N-Desmethylclomipramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>N-Desmethylflunitrazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>N-Desmethyltramadol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>N-Desmethyltrimipramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Neomycin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nitrazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norbenzoylecgonine</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norcocaethylene</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norcodeine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nordiazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norfentanyl</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 17 of 22

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Nor-LAAM</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nor-LSD/Nor-ISO-LSD</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Normeperidine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Normeperidinic acid</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Normorphine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Noroxycodone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Noroxymorphone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Norpropoxyphene</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Noscapine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>O-Desmethyltramadol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>. Oxazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Oxprenolol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>p-Acetamidophenyl-beta-D-glucuronide</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Papaverine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Pemoline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Penicillin G</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Pentazocine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Pentobarbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Perphenazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structuraly Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Phendimetrazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phenelzine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phenothiazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phentermine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phenyibutazone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phenylethyamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phenylpropanolamine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>R,R (-)-Pseudoephedrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine Morpholine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>PMA</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>PMMA</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Prednisolone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Prilocaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Prochlorperazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Progesterone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Promazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Promethazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Propiomazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Propionylpromazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Protriptyline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Quinidine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>R (+) Methcathinone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>R (-) Epinephrine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>R (+) Cathinone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Salbutamol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Sertraline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Stanazalol</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Streptomycin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Sulfadimethoxine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Sulfamethazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Sulfathiazole</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Temazepam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Terbutaline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Tetracycline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Theophylline</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Thioridazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Tramadoi</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Triamcinolone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Triazolam</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Trifluoperazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Trifluopromazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

# Omega Laboratories, inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 20 of 22

Table 5b: Interferences of Structurally Related and Unrelated Compounds on the Omega Laboratories, Inc. Cocaine ELISA Assay   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>-50% CO(250pg/mg)</td><td rowspan=1 colspan=1>+125% CO(625pg/mg)</td><td rowspan=1 colspan=1>+150% CO(750pg/mg)</td></tr><tr><td rowspan=1 colspan=1>Trimeprazine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Trimipramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Tylosin</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Tyramine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Yohimbic acid</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Yohimbine</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Zolpidem</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Zopiclone</td><td rowspan=1 colspan=1>NEG</td><td rowspan=1 colspan=1>POS</td><td rowspan=1 colspan=1>POS</td></tr></table>

CALIBRATOR AND CONTROL: The Omega Laboratories, Inc. ELISA Cocaine Screening Protocol utilizes in-house prepared calibrator and control solutions. This study successfully demonstrated the validation and stability of these solutions and the traceability to NiST standards.

While the typical urine drugs of abuse controls challenge the cutoff calibrator with concentrations of $\pmb { \pmb { \phi } }$ $25 \%$ of the cutoff calibrator in nanograms, the hair testing industry utilizes $-50 \%$ and $+ 1 0 0 \%$ in picograms. Example $- 2 5 \%$ of a nanogram is larger than $50 \%$ of a picogram. Head hair was used in this study.

STABILITY: The Stability Study demonstrated that the mean variance on the concentration of combined cocaine+ cocaine metabolites in 50 head hair samples when stored for an extended period of approximately 2 years was $- 2 3 \%$ .

Additionally, the largest decrease and increase for combined cocaine $^ +$ cocaine metabolites was $45 \%$ EY and $1 7 \%$ , respectively. The general trend of decreasing cocaine and increasing benzoylecgonine may be consistent with non-enzymatic hydrolysis of cocaine to benzoylecgonine. Head hair was used in this study.

Table 6: Cocaine Stability Study Summary of Results   

<table><tr><td rowspan=1 colspan=1>Study Observation</td><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>-Benzoylecgonine</td><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>Cocaethylene</td></tr><tr><td rowspan=1 colspan=1>AverageConcentration(pg/mg)</td><td rowspan=1 colspan=1>5123</td><td rowspan=1 colspan=1>1262</td><td rowspan=1 colspan=1>287</td><td rowspan=1 colspan=1>438</td></tr><tr><td rowspan=1 colspan=1>Mean Change in %</td><td rowspan=1 colspan=1>-23</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Range inConcentration</td><td rowspan=1 colspan=1>369 - 35666</td><td rowspan=1 colspan=1>36 - 9499</td><td rowspan=1 colspan=1>39 - 1963</td><td rowspan=1 colspan=1>24 -2101</td></tr></table>

Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 21 of 22   

<table><tr><td rowspan=1 colspan=1>Study Observation</td><td rowspan=1 colspan=1>Cocaine</td><td rowspan=1 colspan=1>BenzoylecgonIne</td><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>Cocaethylene</td></tr><tr><td rowspan=1 colspan=1>(pg/mg)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>% Max and Mindecrease</td><td rowspan=1 colspan=1>-50% and -5%</td><td rowspan=1 colspan=1>-47% and -2%</td><td rowspan=1 colspan=1>-30% and -0.4%</td><td rowspan=1 colspan=1>-41% and 0%</td></tr><tr><td rowspan=1 colspan=1>% Max and Minincrease</td><td rowspan=1 colspan=1>18% and 4%</td><td rowspan=1 colspan=1>59% and 1%</td><td rowspan=1 colspan=1>47% and 2%</td><td rowspan=1 colspan=1>135% and 0%</td></tr><tr><td rowspan=1 colspan=1>Number thatdecreased inconcentration</td><td rowspan=1 colspan=1>45</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>17</td></tr><tr><td rowspan=1 colspan=1>Number thatincreased inconcentration</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>â€¢16</td></tr></table>

SHIPpinG:A total of 200 hair samples were use in the study; 100 positive samples and 100 negative samples. Head hair was used in this study.

The Shipping Study demonstrated that there was no adverse effect on head hair samples that would affect the screening assay when samples are exposed to extreme temperatures and variations in humidity that might occur during sample transport. The average percent change in Positive Cocaine sample GC/MS results prior to shipping and after shipping was $+ 5 \%$ for all locations combined.

Ainallyheweiscordntsult posthippnfi y CMS)

COSMETIC TREATMENT: Numerous studies have demonstrated that the use of cosmetic treatments can reduce the amount of drugs and metabolites detected in hair specimens. This effect is completely dependent upon the nature of the hair specimen and the treatment used, and is independent of the method of analysis. This study demonstrates that the Omega Laboratories, Inc. ELISA Cocaine Screening Assay is not an exception to this phenomenon.

Sixty six hair specimens previously determined to be negative for cocaine were obtained and the ethnic origin, hair color and curvature were documented. One hundred and ten hair specimens potentially pveor cocaie were obtained nd the ethnic rgn,har color an curvature wer documente. Eac specimen was divided into 2 aliquots. One aliquot was analyzed by the ELISA protocol and by the GC/MS confirmation method.

O t176 reat seens, urinitally STIVEELIA assys e bleac nd thre pet) reported NEG ELISA results after treatment.

ENVIRONMENTAL CONTAMINATION: Preliminary positive hair sample results by the screening method could be due to environmental contamination. All positive samples should be sent for confirmation testing on a reference method to distinguish between true positives and those samples that were positive due to external exposure. Head hair was used for this study.

# CONCLUSION:

The comparison of results of the proposed assay and GC/MS for Cocaine and Cocaine metabolites in head and body hair samples showed the results to be substantially equivalent

The candidate Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites is a

# Omega Laboratories, Inc. 510(k) Summary Omega Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Page 22 of 22

Cocaine Metabolites (Cocaine) predicate device based on acceptable performance studies, including precision, specificity, interference (including cosmetic effects) and removal of environmental contamination.

# November 13, 2013

Omega Laboratories, Inc. C/O Robert J. Bard, JD 400 North Cleveland MOGADORE OH 44260

Re: K131128 Trade/Device Name: Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites Regulation Number: 21 CFR 862.3250 Regulation Name: Cocaine and cocaine metabolite test system Regulatory Class: II Product Code: DIO Dated: September 18, 2013 Received: October 1, 2013

Dear Mr. Bard:

We have reviewed your Section $\pmb { 5 } | \pmb { 0 } ( \pmb { \mathrm { k } } )$ premarket notification of intent to market the device referenced above and have deternined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concering your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 ). please go to htp://wwwv.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Pan 807.97). For questions regarding the reporting of adverse cvents under the MDR regulation (21 CFR Part 803). please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.hum for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, Intemational and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Intemet address http://www.fda.gov/MedicalDevices/ResourcesforYou/lndustry/default.hum.

Sincerely yours.

Carol C. Benson -S for

Courtney H. Lias. Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number: k131128

# Device Name: Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites

Indications for Use:

The Omega Laboratories Hair Drug Screening Assay for Cocaine and Cocaine Metabolites (Cocaine) is an in vitro diagnostic test that is intended for the qualitative detection of Cocaine at or above $5 0 0 p \mathrm { \ p g / m g }$ in human head and body hair. To confirm a screen positive result, a more specific alternate chemical method, such as Gas Chromatography/Mass Spectrometry (GC/MS) operating in the selected ion monitoring (SIM) mode is the preferred method with deuterated internal standards. Professional judgment should be applied to any drug of abuse test result, particularly when presumptive positive results are obtained.

This test is intende exclusively for single laboratoryuse nly and is not intended r a to anyone.

# Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Denise Johnson-lyles -S

Division Sign-Off Office of In Vitro Diagnostics and Radiological Health

510(k): k131128